Multi-target modulation for treating fibrosis and inflammatory conditions
作者： Neil Desai
DOI:
关键词:
摘要: The present invention relates to compositions comprising one or more active agents that selectively modulate the expression of two genes, for example at post-transcription level, are involved in fibrosis and/or inflammatory conditions. Also provided methods using such treating fibrotic diseases, as well other diseases including and cancer.
lens.org 参考文章(16)
C. Frank Bennett, Nicholas M. Dean, J. Gordon Foulkes, William A. Gaarde, Susan M. Freier, Modulation of transforming growth factor-beta 1 expression ,(2011)
Samir M. Mitragotri, Tracy Hsu, Skin permeating and cell entering (space) peptides and methods of use thereof ,(2011)
Sreenivas Punna, Andrew M. K. Pennell, Solomon Ungashe, Zheng Wei, Arindrajit Basak, Jimmie Moore, Jeff Jin, Ccr2 inhibitors and methods of use thereof ,(2007)
Jayakrishna Ambati, VEGF-A as an inhibitor of angiogenesis and methods of using same ,(2004)
Young-Kook Choi, Ik-Jae Moon, Jong-Gu Park, Kwankyu Park, TGF-beta-specific covalently closed antisense molecule ,(2002)
Timothy J. Pelura, Conjoint therapy for treating fibrotic diseases ,(2007)
Guangming Li, Qing Xie, Yi Shi, Dingguo Li, Mingjun Zhang, Shan Jiang, Huijuan Zhou, Hanming Lu, Youxin Jin, Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats Journal of Gene Medicine. ,vol. 8, pp. 889- 900 ,(2006) , 10.1002/JGM.894
J George, M Tsutsumi, siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Therapy. ,vol. 14, pp. 790- 803 ,(2007) , 10.1038/SJ.GT.3302929
Y Takabatake, Y Isaka, M Mizui, H Kawachi, F Shimizu, T Ito, M Hori, E Imai, Exploring RNA interference as a therapeutic strategy for renal disease Gene Therapy. ,vol. 12, pp. 965- 973 ,(2005) , 10.1038/SJ.GT.3302480
Jiu-Cun Wang, Syeling Lai, Xinjian Guo, Xuefeng Zhang, Benoit de Crombrugghe, Sonali Sonnylal, Frank C Arnett, Xiaodong Zhou, Attenuation of fibrosis in vitro and in vivo with SPARC siRNA Arthritis Research & Therapy. ,vol. 12, pp. 1- 9 ,(2010) , 10.1186/AR2973